Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Retractable Technologies, Inc. (NYSE MKT: RVP) reports the following results of operations for the second quarter, and the first half, of 2013:
Comparison of Three Months Ended June 30, 2013 and June 30, 2012
Domestic sales accounted for 69.0% and 77.9% of the revenues for the three months ended June 30, 2013 and 2012, respectively. Domestic revenues decreased 29.9% principally due to lower average selling prices and lower volumes. Domestic unit sales decreased 18.7% due to decreased sales of the 1mL syringe. Domestic unit sales were 55.6% of total unit sales for the three months ended June 30, 2013.
Hey, check out all the research scientist jobs. Post your resume today!
